California Cancer Reporting System Standards, Volume III
CCR ID |
NAACCR ID |
E1813 |
1117 |
SEER
This field identifies whether other metastatic involvement, other than bone, brain, liver, lung or distant lymph nodes exists. Some examples include but are not limited to the adrenal gland, bone marrow, pleura, peritoneum and skin. The six Mets at Dx-Metastatic Sites fields provide information on specific metastatic sites for data analysis.
Admissions, Tumors
1
0 |
None; no other metastases |
1 |
Yes; distant metastases in known site(s) other than bone, brain, liver, lung, or distant lymph nodes |
8 |
Not applicable |
9 |
Unknown whether any other metastatic site. Not documented in patient record. |
If Date of Diagnosis is 2016 and greater, then convert non-blank, non-numeric value to 9
Tumor
New Case Consolidation
If all of these conditions are true:
Any of these conditions are true:
Admission’s Date of Diagnosis year is 2016-9998
Tumor’s Date of Diagnosis year is 2016-9998
Tumor’s Date of Diagnosis year is blank AND the admission’s Date of 1st Contact year is 2016-9998
Admission’s Date of Diagnosis year is blank AND the admission’s Date of 1st Contact year is 2016-9998
Admission's value is NOT blank
Admission and tumor’s values are different
Then list for review.
Admission
Manual Update
Yes
IF1148: Mets at DX-BBDLLO, HemeRetic
N/A
08/2016 |
Per NAACCR v16, new data field implemented. |